Patients with stable RRMS (relapsing-remitting multiple sclerosis) showed comparable levels, whereas active RRMS patients demonstrated elevated frequencies of CD4+NKG2D+ T cells (Figure 1A) in the periphery. The gene discussed is CD4; the disease is relapsing-remitting multiple sclerosis.